King of Prussia, PA, United States of America

Leandro Luiz Dos Santos

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Leandro Luiz Dos Santos: Innovator in Vitiligo Treatment

Introduction

Leandro Luiz Dos Santos is a notable inventor based in King of Prussia, Pennsylvania. He has made significant contributions to the field of dermatology, particularly in the treatment of vitiligo. His innovative work has led to the development of a patent that addresses a critical need in this area.

Latest Patents

Leandro holds a patent for "JAK1 pathway inhibitors for the treatment of vitiligo." This disclosure relates to the use of JAK1 pathway inhibitors and their effectiveness in treating vitiligo, a condition that causes skin discoloration. His patent represents a significant advancement in therapeutic options for patients suffering from this condition. He has 1 patent to his name.

Career Highlights

Leandro is currently employed at Incyte Corporation, a leading biopharmaceutical company focused on innovative medicines. His role at Incyte allows him to work on cutting-edge research and development projects that aim to improve patient outcomes. His expertise in the field has positioned him as a valuable asset to the company.

Collaborations

Throughout his career, Leandro has collaborated with several talented individuals, including Paul Smith and Kurt Andrew Brown. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Leandro Luiz Dos Santos is a dedicated inventor whose work in developing JAK1 pathway inhibitors for vitiligo treatment showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic options for patients, highlighting the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…